Bruker and Isis Pharmaceuticals introduce cultureless microorganism
sensor to Europe
9 October 2006
London, UK. Bruker Daltonics Inc. and Isis Pharmaceuticals Inc. have
introduced the Ibis T5000 biosensor system to the European market. The Ibis
T5000 is an automated biosensor for healthcare research applications that
enables the analysis of viruses, bacteria and fungi without any microbial
culturing or genome sequencing steps.
|
The Ibis T5000 Uses PCR and ESI-TOF Mass
Spectrometry for microorganism analysis (Photo: Business Wire) |
The Ibis T5000 relies on technology and applications developed by Ibis
Biosciences, a division of Isis Pharmaceuticals, incorporating Bruker
Daltonics' micrOTOF ESI time of flight (TOF) mass spectrometer.
Following the announcement of a manufacturing and distribution agreement
between Isis Pharmaceuticals and Bruker Daltonics earlier this year, the
companies have taken the next important step towards commercialization of
the Ibis T5000 biosensor system by entering the large European markets.
Ready-to-use consumable assay kits will be available for applications
such as pan-influenza surveillance (human and avian flu) and detection of
sources of hospital-associated infections, including methicillin-resistant
Staphylococcus aureus (MRSA) strains. Applications will also enable in-depth
characterization of bacterial strain types, antibiotic resistance profiles
and virulence markers. The Ibis T5000 is currently designated for Research
Use Only (RUO).
Michael Treble, President of the Ibis Biosciences division and Vice
President of Isis Pharmaceuticals, commented, "We're excited about the
European introduction of the Ibis T5000 biosensor system, which has the
potential to revolutionize infectious microorganism detection. And we're
especially pleased that our partner, Bruker Daltonics, will be
manufacturing, installing and servicing the Ibis T5000 instruments. Bruker
has an extensive global infrastructure to support customers at the point of
use, enabling Ibis to focus on the development, manufacture and supply of
reagent kits."
Wolfgang Pusch, Assistant Vice President for Clinical Research Solutions
of Bruker Daltonics, stated: "The Ibis T5000 biosensor system analyzes the
DNA of infectious disease microorganisms, and is an ideal complement to
Bruker Daltonics' existing MALDI BioTyper platform for microorganism
identification based on protein signatures. With the Ibis T5000 we further
expand the scope of our products in microbiology and can now even address
applications as important as hospital-associated infections and influenza
surveillance. This is a further milestone in establishing Bruker Daltonics
as the leading supplier for mass spectrometry-based systems for clinical
research, including infectious disease research and epidemiology."
To top
|